Omeprazole Noridem

Omeprazole, the active ingredient in Omeprazole Noridem, is a proton pump inhibitor presented as a 20 mg tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults.

GNH USA supplies Omeprazole Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole Noridem is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related gastrointestinal conditions: - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining. - Erosive oesophagitis: heals erosive lesions and prevents recurrence. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion. - Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates.

Omeprazole Noridem may cause a range of adverse reactions.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually self‑limiting. - Abdominal pain or discomfort: intermittent. - Nausea: occasional. - Flatulence: mild. - Constipation: occasional.

Serious or Rare Side Effects: - Clostridioides difficile infection: may present with severe diarrhoea. - Acute interstitial nephritis: renal inflammation requiring medical attention. - Hypomagnesemia: low serum magnesium levels, potentially causing muscle cramps. - Stevens‑Johnson syndrome: severe skin reaction requiring urgent care. - Fracture risk: increased risk of hip, wrist or spine fractures with long‑term use. - Vitamin B12 deficiency: reduced absorption over prolonged therapy.

When prescribing Omeprazole Noridem, consider the following precautions: - Assess renal function: adjust use in severe renal impairment. - Evaluate hepatic function: use with caution in moderate to severe liver disease. - Review long‑term therapy: limit duration to the shortest effective period. - Monitor for drug‑induced nutrient deficiencies: especially magnesium and vitamin B12. - Counsel patients on symptom monitoring: advise reporting persistent abdominal pain or unexplained weight loss. - Store at below 25°C: keep in the original packaging, protect from moisture and light.

Omeprazole Noridem can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk. - Atazanavir: decreased absorption, compromising HIV therapy. - Dasatinib: lowered plasma concentrations, reducing oncologic efficacy.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, necessitating more frequent monitoring. - Phenytoin: may lower omeprazole levels, reducing acid suppression. - Methotrexate: increased systemic exposure, especially at high doses. - Ketoconazole: reduced absorption of the antifungal, diminishing effectiveness.